Navigation Links
Neisseria gonorrhoeae Culture

ProductsNeisseria gonorrhoeae Culture
Company ARUP Laboratories
Item Neisseria gonorrhoeae Culture
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Chlamydia trachomatis&Neisseria gonorrhoeae by Amplified Detection (APTIMA)
2. Chlamydia trachomatis & Neisseria gonorrhoeae DNA Probe
3. Chlamydia trachomatis & Neisseria gonorrhoeae by Amplified Detection (APTIMA), ThinPrep
4. Culture, Neisseria gonorrhoeae
5. Neisseria gonorrhoeae and Chlamydia trachomatis, DNA Probe
6. Neisseria gonorrhoeae by Amplified Detection (APTIMA)
7. Neisseria gonorrhoeae Antibody
8. Neisseria gonorrhoeae DNA Probe
9. Neisseria meningitidis Types A & C, IgG (ELISA)
10. Culture Incubator
11. Pathfinder Chlamydia Culture Confirmation Test
Galilean Loupes...
... Over 40 cm field-of-view enables high-quality ... system with scalable 32-channel architecture. New powerful ... 3.0T imaging up to 80 mT/m ... SAR management to fully exploit the power ...
... fusion system represents a breakthrough for patients ... spine. The system gathers bone during decompression, ... of bone into the implant's chamber produces ... harvest from the iliac crest. The BAK/C ...
Signa Profile is built on the Signa foundation to deliver speed & image quality....
Medicine Products:
(Date:8/3/2015)... ... 03, 2015 , ... Sensato and Divurgent ... Healthcare Systems” This three-day, highly interactive and immersive workshop, has been developed ... to the tactics, techniques and practices required to design and develop highly secure ...
(Date:8/3/2015)... ... August 03, 2015 , ... A July 9 article from USA ... recent years, according to the American Dental Association. According to a study by the ... from 1.1 million in a single year to 2.2 million a year. Dentists and ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) ... , The acquisition includes all of IBAM NA’s cyclotron sites and research and ... a robust regionally located business, as well as a large manufacturing hub in Noblesville, ...
(Date:8/3/2015)... Florida (PRWEB) , ... August 03, 2015 , ... Constantin ... pain accompanied by tissue injury caused by diabetes after many years of suffering and ... many times, and he didn’t want to ask for extra time off or wait ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... risk management and investigative services, has introduced a new logo and comprehensive ... solutions that improve business outcomes for its customers. EMSI’s new tagline, “Powerful ...
Breaking Medicine News(10 mins):Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... must weigh risks, benefits, experts say , , TUESDAY, Nov. ... data confirms that some common inhalers don,t boost the ... as chronic obstructive pulmonary disease (COPD). , In fact, ... in patients with COPD, the fourth biggest killer in ...
... 25 Nationwide Health Properties, Inc. (NYSE: NHP ) ... U.K. nursing home property company that may be in default ... the similarity of the names, it wanted to clarify that ... , Nationwide Health Properties, Inc. is a real ...
... (FRG) is pleased to announce the hiring of Dr. ... Operations. Katyal will be joining them from,West Penn Hospital, ... and Past President of the Pittsburgh Radiology Society. , ... widely regarded as the preeminent cardiovascular imager in,Western Pennsylvania. ...
... public event held today in New Orleans, the Department ... jointly announced the selection of adjacent downtown sites for ... projects, called the Veterans Affairs Medical Center and the ... greatly needed health care capability lost in New Orleans ...
... Nov. 25 The U.S. military provides its members ... commitments. But a researcher at Kansas State University ... be enough to maintain a supreme equilibrium. , ... of psychology at K-State, and colleagues have been studying ...
... components to determine levels of halogens , ... Minneapolis ... a leading materials testing laboratory, is helping companies adhere ... led to concerns regarding the environmental and health impact of halogens ...
Cached Medicine News:Health News:Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients 2Health News:Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients 3Health News:Foundation Radiology Group Adds World Class Cardiovascular Imaging Expert, Dr. Sanj Katyal, to Staff 2Health News:VA and Louisiana State University Announce Site Selections for New Orleans Medical Center Projects 2Health News:VA and Louisiana State University Announce Site Selections for New Orleans Medical Center Projects 3Health News:K-State Psychologist Studies Ways to Improve Soldiers' Work-Life Relationship 2Health News:Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment 2
(Date:7/31/2015)... , July 31, 2015  Xcelience, a contract ... it has made a structured cash investment in ... specializing in milling, micronization and powder size classification ... grow Powdersize,s business while simultaneously adding a complete ... portfolio of capabilities. "As we ...
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6